Drug & intervention
GlucaGen
RxCUI 151823
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
GlucaGen
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
5 shownA Stable Glucagon Analog Administered by a Bihormonal Closed Loop SystemNCT05454709 · 2023-12-29
WITHDRAWNGlucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 DiabetesNCT05379686 · 2022-09-21
COMPLETEDLow-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 DiabetesNCT05076292 · 2021-11-23
COMPLETEDA Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes SubjectsNCT03378635 · 2017-12-07
COMPLETEDA Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusNCT03216226 · 2017-06-28
COMPLETEDConditions being studied
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.